menu search

Verve to present interim data from the heart-1 phase 1b clinical trial of verve-101 in hefh patients at the american heart association’s scientific sessions 2023

Company to hold investor event in conjunction with data presentation on November 12, 2023 BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — Verve Therapeuti...

September 26, 2023, 10:30 am

Roivant announces positive initial imvt-1402 phase 1 sad and 300 mg subcutaneous mad results

IMVT-1402 subcutaneous (SC) doses achieved peak Immunoglobulin G (IgG) reductions that are similar to those previously observed with batoclimab No dec...

September 26, 2023, 10:00 am

Immunovant announces positive initial imvt-1402 phase 1 sad and 300 mg subcutaneous mad results

IMVT-1402 subcutaneous (SC) doses achieved peak Immunoglobulin G (IgG) reductions that are similar to those previously observed with batoclimab No dec...

September 26, 2023, 10:00 am

Omega therapeutics: good news met with share markdown

It seems to take a lot to impress those invested in Omega Therapeutics Inc. The shares fell after the biotech reported what on the face of it were p...

September 26, 2023, 9:45 am

Biovie to announce topline data from phase 3 alzheimer's disease trial by year-end

BioVie Inc (NASDAQ:BIVI) said the last patient has completed their final visit at week 30 in their phase ...

September 26, 2023, 9:11 am

Tiziana life sciences initiates multi-center phase 2a clinical trial of intranasal foralumab for na-spms

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it has commenced site initiation for its lead intranasal foralumab program entering ...

September 26, 2023, 8:16 am

Chitogenx concludes enrolment for its us phase i/ii rotator cuff tear repair clinical trial

ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) said it has concluded the enrolment of 20 subjects in its US multi-site rotator cuff tear repair ...

September 26, 2023, 8:11 am

Verve to present interim data from the heart-1 phase 1b clinical trial of verve-101 in hefh patients at the american heart association's scientific sessions 2023

Company to hold investor event in conjunction with data presentation on November 12, 2023 Company to hold investor event in conjunction with data pres...

September 26, 2023, 6:30 am

Immunovant to host conference call and webcast to report initial imvt-1402 phase 1 results on september 26, 2023

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives ...

September 26, 2023, 3:01 am

Immunovant to host conference call and webcast to report initial imvt-1402 phase 1 results on september 26, 2023

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives f...

September 25, 2023, 11:01 pm

The next phase of the commodities supercycle is here. are you ready?

Since the middle of 2020, everyone from Goldman Sachs, JPMorgan to Bank of America called the beginning of a new Supercycle and hot-listed Commodities...

September 25, 2023, 6:59 pm

Omega therapeutics to host conference call to discuss preliminary clinical data for otx-2002 from ongoing mychelangelo™ i trial on september 26

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pio...

September 25, 2023, 4:00 pm

An updated view on fulcrum therapeutics

Fulcrum Therapeutics, Inc. has had some key potential catalysts resolved positively recently. These included the FDA lifted the clinical hold on Fulcr...

September 25, 2023, 2:10 pm

Sec obtains thousands of wall street staffers' whatsapp messages as probe widens: sources

In the latest phase of the probe of more than a dozen investment advisers, the SEC has in recent mo...

September 25, 2023, 1:41 pm

Novartis (nvs) lutathera meets primary goal in phase iii study

Novartis' (NVS) radioligand therapy Lutathera reports statistically significant and clinically meaningful progression-free survival in first line adva...

September 25, 2023, 1:32 pm

Gold price forecast: xau/usd remains stuck below key averages, what’s next?

Gold price is easing toward $1,920, making it for a negative start to a key week ahead. The United States Dollar (USD) and the US Treasury bond yields...

September 25, 2023, 3:14 am

Oxford cannabinoid technologies completes final dose in phase i trial of lead asset

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) has successfully administered the final dose of its lead drug candidate, OCT46120...

September 25, 2023, 2:47 am

Gbp/usd consolidates in a range below mid-1.2200s, seems vulnerable near multi-month low

GBP/USD enters a bearish consolidation phase near a multi-month low touched last Friday. The USD contin...

September 25, 2023, 1:29 am

Week in review: everest acquires novel autoimmune therapy in $132 million agreement

Shanghai Everest Medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from Kezar Life Sciences of South San Francisco in a...

September 24, 2023, 10:33 pm

3 top stocks that just went on sale

Enphase is the cheapest it has ever been on a free-cash-flow basis. Toro hopes to restart sales growth,...

September 24, 2023, 5:47 am


Search within

Pages Search Results: